Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Authors' Reply
Alimentary Pharmacology & Therapeutics · 2026-11-03
DOI: 10.1111/apt.71077 ↗At a glance
Leserbrief in Alimentary Pharmacology & Therapeutics, published online on 2026-11-03. Written by M F W Gee and 4 co-authors. Institution: Siemens Healthineers, Tarrytown, New York, USA. 9 references.
Abstract (original language)
M. F. W. Gee: conceptualization, investigation, writing – original draft, methodology, writing – review and editing, formal analysis. E. B. De Vol: conceptualization, investigation, writing – original draft, methodology, writing – review and editing, formal analysis, software, data curation. H. R. Levy: conceptualization, investigation, writing – original draft, writing – review and editing, methodology, formal analysis, supervision, project administration. A. T. Boltyenkov: conceptualization, investigation, writing – original draft, writing – review and editing, methodology, formal analysis. Sanyal. AJ: validation, writing – review and editing. The authors have nothing to report. This article is linked to Gee et al. papers. To view these articles, visit https://doi.org/10.1111/apt.70846 and https://doi.org/10.1111/apt.71020. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
Authors and institutions
- Siemens Healthineers, Tarrytown, New York, USA.
- Temerty Faculty of Medicine, Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
- Division of Gastroenterology, Hepatology and Nutrition, Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.
ORCID profiles: M F W Gee, E B De Vol, H R Levy, A T Boltyenkov, Sanyal Aj
Cite
APA
Gee, M. F. W., De Vol, E. B., Levy, H. R., Boltyenkov, A. T., & Aj, S. (2026). Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Authors' Reply. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.71077
Vancouver
Gee MFW, De Vol EB, Levy HR, Boltyenkov AT, Aj S. Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.71077
BibTeX
@article{Gee2026,
author = {Gee, M F W and De Vol, E B and Levy, H R and Boltyenkov, A T and Aj, Sanyal},
title = {Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Authors' Reply},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
doi = {10.1111/apt.71077}
}
EUVIMED